According to Jeff Richardson of Amgen, this is theCalifornia-based company's first presence in the area. The companyhas over 500 employees in its headquarters and plans to put 100 ofits research staff here. The remainder of the space will be leasedout.

In a released statement, Kevin Sharer, the company's chiefexecutive says, "It's important to Amgen's growth and success tohave a strong presence in the Cambridge-Boston biotechnologycommunity." Amgen also has facilities in Colorado, Kentucky,Washington DC and Puerto Rico and has 24 offices throughout theworld.

This area's office market has been severely impacted by therecent downturn in the economy as many of its dotcoms and hightech-related businesses went under or cut back. But it stillmaintains a strong biotech presence as many companies opt to beclose to other biotech companies as well as to the localuniversities and hospitals.

Continue Reading for Free

Register and gain access to:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.